U.S. Court in Missouri Refuses to Dismiss Whistleblower Action Against Device Maker Alleging Off-Label Promotion
- April 08, 2022
Integra Life Sciences Corp. must face a whistleblower action alleging it unlawfully promoted medical devices for off-label uses causing health care providers to submit false claims to the federal government for reimbursement, the U.S. District Court for the Western District of Missouri held April 6.
ARTICLE TAGS
You must be logged in to access this content.